# Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

> **NCT04641884** · — · UNKNOWN · sponsor: **Nantes University Hospital** · enrollment: 85 (estimated)

## Conditions studied

- Bullous Pemphigoid
- Immunotherapy
- Programmed Cell Death Ligand 1

## Interventions

- **OTHER:** Not concerned

## Key facts

- **NCT ID:** NCT04641884
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04641884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04641884, "Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04641884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*